HomeCompareRPGHF vs JNJ

RPGHF vs JNJ: Dividend Comparison 2026

RPGHF yields 118.34% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RPGHF wins by $8.00M in total portfolio value
10 years
RPGHF
RPGHF
● Live price
118.34%
Share price
$1.69
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.03M
Annual income
$3,014,923.49
Full RPGHF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — RPGHF vs JNJ

📍 RPGHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRPGHFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RPGHF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RPGHF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RPGHF
Annual income on $10K today (after 15% tax)
$10,059.17/yr
After 10yr DRIP, annual income (after tax)
$2,562,684.97/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, RPGHF beats the other by $2,558,698.98/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RPGHF + JNJ for your $10,000?

RPGHF: 50%JNJ: 50%
100% JNJ50/50100% RPGHF
Portfolio after 10yr
$4.03M
Annual income
$1,509,806.45/yr
Blended yield
37.48%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

RPGHF
No analyst data
Altman Z
9.1
Piotroski
7/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RPGHF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRPGHFJNJ
Forward yield118.34%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$8.03M$30.3K
Annual income after 10y$3,014,923.49$4,689.40
Total dividends collected$7.29M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RPGHF vs JNJ ($10,000, DRIP)

YearRPGHF PortfolioRPGHF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$22,534$11,834.32$10,592$272.30+$11.9KRPGHF
2$49,035$24,923.21$11,289$357.73+$37.7KRPGHF
3$103,153$50,685.22$12,123$472.89+$91.0KRPGHF
4$210,022$99,648.81$13,141$629.86+$196.9KRPGHF
5$414,339$189,615.20$14,408$846.81+$399.9KRPGHF
6$792,949$349,606.93$16,021$1,151.60+$776.9KRPGHF
7$1,473,753$625,296.70$18,122$1,588.22+$1.46MRPGHF
8$2,663,044$1,086,129.08$20,930$2,228.20+$2.64MRPGHF
9$4,683,678$1,834,220.22$24,792$3,191.91+$4.66MRPGHF
10$8,026,459$3,014,923.49$30,274$4,689.40+$8.00MRPGHF

RPGHF vs JNJ: Complete Analysis 2026

RPGHFStock

RPMGlobal Holdings Limited develops and provides mining software solutions in Australia, Asia, the Americas, Africa, and Europe. It operates through Software and Advisory divisions. The company provides software licensing, consulting, implementation, and support services; and technical, advisory, and training services. It also offers enterprise planning framework; Open Cut Phosphate, Open Pit Metals, Open Pit Diamond, Quarry, and Steep coal solutions; RESERVER, a mine reserve model; EmissionsManager, a SaaS based solution for collecting, calculating, monitoring, and reporting emissions data; XECUTE that enables planners to build a term schedule; Asset Management; XPAC solution, a scheduling software; XACT, a short-term mining operation solution, as well as Enterprise Optimiser; IMAFS, which uses AI to enhance inventory management; and Schedule Optimisation Tool for scenario planning and comparisons. In addition, the company provides Attain, a flexible mine schedule optimization tool; Strategic Design Optimiser; Stratigraphic metal solution; underground metals solution; underground coal solution; underground potash solution; product optimizer; HAULSIM, a 3-D discrete event simulation software; SIMULATE, an event simulation software for original equipment manufacturers; TALPAC-3D, a truck and loader productivity calculator; TALPAC, a truck and loader productivity solution for underground coal mines; Open Cut Coal solution; and DRAGSIM, a dragline simulation software. Further, it offers XERAS Enterprise, a budgeting solution; XERAS, a financial modelling solution; ShiftManager, a mine engineering and shift management software; MINVU, a mining management software; and AMT, an asset maintenance software for contractors and OEMs, as well as AMT4SAP. The company was formerly known as RungePincockMinarco Limited and changed its name to RPMGlobal Holdings Limited in March 2017. RPMGlobal Holdings Limited was founded in 1968 and is headquartered in Brisbane, Australia.

Full RPGHF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this RPGHF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RPGHF vs SCHDRPGHF vs JEPIRPGHF vs ORPGHF vs KORPGHF vs MAINRPGHF vs ABBVRPGHF vs MRKRPGHF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.